|
91
|
296
|
4uxlA |
Structure of human ros1 kinase domain in complex with pf-06463922 |
|
81
|
273
|
4wt6A |
Crystal structure of human pim-1 kinase in complex with a thiadiazolamine-indole inhibitor. |
|
72
|
291
|
4usdA |
Human stk10 (lok) with sb-633825 |
|
99
|
337
|
4wbbB |
Single turnover autophosphorylation cycle of the pka riib holoenzyme |
|
75
|
287
|
4x3fA |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
79
|
280
|
4x3jA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
74
|
308
|
4uyaA |
Structure of mlk4 kinase domain with atpgammas |
|
96
|
326
|
4wrgA |
1.9 angstrom structure of egfr kinase domain |
|
90
|
301
|
4uwcA |
Fibroblast growth factor receptor 1 kinase in complex with jk-p3 |
|
91
|
327
|
4wkqA |
1.85 angstrom structure of egfr kinase domain with gefitinib |
|
162
|
464
|
4wg5A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1647 |
|
87
|
262
|
4uzdA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
83
|
268
|
4uzhA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
76
|
273
|
4wsyA |
Crystal structure of human pim-1 kinase in complex with a thiazolamine-indazole inhibitor. |
|
77
|
269
|
4wa9A |
The crystal structure of human abl1 wild type kinase domain in complex with axitinib |
|
103
|
337
|
4x6qC |
An isoform-specific myristylation switch targets riib pka holoenzymes to membranes |
|
91
|
303
|
4v04A |
Fgfr1 in complex with ponatinib. |
|
117
|
370
|
4wuaA |
Crystal structure of human srpk1 complexed to an inhibitor srpin340 |
|
92
|
300
|
4uv0A |
Structure of a semisynthetic phosphorylated dapk |
|
89
|
302
|
4uwbA |
Fibroblast growth factor receptor 1 kinase in complex with jk-p5 |
|
79
|
328
|
4wd5A |
Crystal structure of egfr 696-1022 t790m in complex with ql-x138 |
|
98
|
303
|
4x0mA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
102
|
356
|
4w4yA |
Jnk2/3 in complex with 3-(4-{[(4-methylphenyl)carbamoyl]amino}-1h-pyrazol-1-yl)-n-(2-methylpyridin-4-yl)benzamide |
|
76
|
283
|
4v0gB |
Jak3 in complex with a covalent egfr inhibitor |
|
100
|
303
|
4x2fA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
91
|
301
|
4uwyA |
Fgfr1 apo structure |
|
75
|
274
|
4wo5A |
Crystal structure of a braf kinase domain monomer |
|
169
|
465
|
4wg3A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1610 |
|
108
|
356
|
4whzA |
Design and synthesis of highly potent and isoform selective jnk3 inhibitors: sar studies on aminopyrazole derivatives |
|
95
|
291
|
4w8eA |
Structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06645342) |
|
108
|
355
|
4x21A |
The map kinase jnk3 as target for halogen bonding |
|
89
|
301
|
4wunA |
Structure of fgfr1 in complex with azd4547 (n-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-5-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide) at 1.65 angstrom |
|
81
|
274
|
4wnpA |
Structure of ulk1 bound to a potent inhibitor |
|
103
|
356
|
4w4vA |
Jnk2/3 in complex with 3-(4-{[(2-chlorophenyl)carbamoyl]amino}-1h-pyrazol-1-yl)-n-(2-methylpyridin-4-yl)benzamide |
|
111
|
356
|
4w4wA |
Jnk2/3 in complex with n-(2-methylpyridin-4-yl)-3-{4-[(phenylcarbamoyl)amino]-1h-pyrazol-1-yl}benzamide |
|
88
|
302
|
4v05A |
Fgfr1 in complex with azd4547. |
|
170
|
518
|
4wnkA |
Crystal structure of bovine g protein coupled-receptor kinase 5 in complex with ccg215022 |
|
160
|
506
|
4wboA |
Bovine g protein coupled receptor kinase 1 in complex with amlexanox |
|
107
|
350
|
4x6rA |
An isoform-specific myristylation switch targets riib pka holoenzymes to membranes |
|
101
|
356
|
4w4xA |
Jnk2/3 in complex with 3-(4-{[(4-fluorophenyl)carbamoyl]amino}-1h-pyrazol-1-yl)-n-(2-methylpyridin-4-yl)benzamide |
|
100
|
303
|
4x2kA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
100
|
303
|
4x2jA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
83
|
299
|
4uxqA |
Fgfr4 in complex with ponatinib |
|
86
|
273
|
4wnoA |
Structure of ulk1 bound to an inhibitor |
|
93
|
290
|
4wnmA |
Syk catalytic domain in complex with a potent triazolopyridine inhibitor |
|
98
|
290
|
4w8dA |
Crystal structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06454589). |
|
80
|
288
|
4x3fC |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
101
|
303
|
4x2nA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
90
|
301
|
4v01A |
Fgfr1 in complex with ponatinib (co-crystallisation). |
|
78
|
273
|
4wrsA |
Crystal structure of human pim-1 kinase in complex with an azaspiro pyrazinyl-indazole inhibitor. |
